Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1979 3
1980 4
1981 4
1982 3
1983 2
1984 1
1985 1
1986 2
1987 2
1988 2
1989 5
1990 1
1991 3
1992 2
1994 4
1995 4
1996 2
1998 1
2000 3
2001 2
2004 1
2005 1
2007 2
2008 1
2009 1
2011 1
2012 1
2016 2
2020 0
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 8197962

62 results
Results by year
Filters applied: . Clear all
Page 1
Osmotic blood-brain barrier disruption: CT and radionuclide imaging.
Roman-Goldstein S, Clunie DA, Stevens J, Hogan R, Monard J, Ramsey F, Neuwelt EA. Roman-Goldstein S, et al. AJNR Am J Neuroradiol. 1994 Mar;15(3):581-90. AJNR Am J Neuroradiol. 1994. PMID: 8197962
In vivo assessment of the window of barrier opening after osmotic blood-brain barrier disruption in humans.
Siegal T, Rubinstein R, Bokstein F, Schwartz A, Lossos A, Shalom E, Chisin R, Gomori JM. Siegal T, et al. J Neurosurg. 2000 Apr;92(4):599-605. doi: 10.3171/jns.2000.92.4.0599. J Neurosurg. 2000. PMID: 10761648
Osmotic blood-brain barrier modification: clinical documentation by enhanced CT scanning and/or radionuclide brain scanning.
Neuwelt EA, Specht HD, Howieson J, Haines JE, Bennett MJ, Hill SA, Frenkel EP. Neuwelt EA, et al. AJR Am J Roentgenol. 1983 Oct;141(4):829-35. doi: 10.2214/ajr.141.4.829. AJR Am J Roentgenol. 1983. PMID: 6412531
Effects of gadopentetate dimeglumine administration after osmotic blood-brain barrier disruption: toxicity and MR imaging findings.
Roman-Goldstein SM, Barnett PA, McCormick CI, Ball MJ, Ramsey F, Neuwelt EA. Roman-Goldstein SM, et al. AJNR Am J Neuroradiol. 1991 Sep-Oct;12(5):885-90. AJNR Am J Neuroradiol. 1991. PMID: 1950917
Comparison of blood-brain barrier disruption by intracarotid iopamidol and methylglucamine iothalamate.
Sage MR, Wilcox J, Evill CA, Benness GT. Sage MR, et al. AJNR Am J Neuroradiol. 1983 Jul-Aug;4(4):893-5. AJNR Am J Neuroradiol. 1983. PMID: 6410875
Reversible osmotic blood-brain barrier disruption in humans: implications for the chemotherapy of malignant brain tumors.
Neuwelt EA, Frenkel EP, Diehl J, Vu LH, Rapoport S, Hill S. Neuwelt EA, et al. Neurosurgery. 1980 Jul;7(1):44-52. doi: 10.1227/00006123-198007000-00007. Neurosurgery. 1980. PMID: 6251399
Monitoring of methotrexate delivery in patients with malignant brain tumors after osmotic blood-brain barrier disruption.
Neuwelt EA, Diehl JT, Vu LH, Hill SA, Michael AJ, Frenkel EP. Neuwelt EA, et al. Ann Intern Med. 1981 Apr;94(4 pt 1):449-54. doi: 10.7326/0003-4819-94-4-449. Ann Intern Med. 1981. PMID: 6782926
Radionuclide assessment of blood-brain barrier disruption performed for chemotherapy of high grade malignant brain gliomas.
Singh A, Belshe BD, Gumerlock MK. Singh A, et al. Int J Rad Appl Instrum B. 1991;18(6):641-5. doi: 10.1016/0883-2897(91)90034-i. Int J Rad Appl Instrum B. 1991. PMID: 1743987
[Extravasation of contrast media in brain parenchyma and cerebrospinal fluid space after CT or DSA of thorax or abdomen].
Bretscheider T, Troidl N, Strotzer M, Fröhlich D, Hansen E. Bretscheider T, et al. Rofo. 2001 Jun;173(6):497-501. doi: 10.1055/s-2001-14984. Rofo. 2001. PMID: 11471289 German.
Pharmacokinetics of methotrexate in cerebrospinal fluid and serum after osmotic blood-brain barrier disruption in patients with brain lymphoma.
Zylber-Katz E, Gomori JM, Schwartz A, Lossos A, Bokstein F, Siegal T. Zylber-Katz E, et al. Clin Pharmacol Ther. 2000 Jun;67(6):631-41. doi: 10.1067/mcp.2000.106932. Clin Pharmacol Ther. 2000. PMID: 10872645
62 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback